GSK and Viome expand microbiome-based cancer therapeutics deal 29-Oct-2021 By Will Chu GlaxoSmithKline (GSK) are to expand on an existing collaboration with Viome that looks into links between the gut microbiome and certain cancers.
Viome raises more money, highlighting growth opportunities in personalized nutrition category 03-Dec-2019 By Danielle Masterson The increasing financial backing for biomarker testing such what Viome offers is an example of the expansion of personalized nutrition and gut health.